Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

105.19 +0.31 (+0.30%)
Official Closing Price Updated: 4:10 PM EST, Dec 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Abbott Stock Gains On Q3 Performance, 10% Organic Diagnostics Revenue Growth, Raised Annual Outlook
Abbott Laboratories (NYSE: ABT) has reported Q3 FY23 adjusted EPS of $1.14, almost similar to $1.15 a year ago, beating the con 
Via Benzinga
Abbott Raises Outlook, Boosted By 'Whopping' Growth Of Diabetes Device
The company raised the midpoint of its earnings outlook. 
Via Investor's Business Daily
US Stocks Set For Weak Open Ahead Of Tesla Q3 Print: Why This Analyst Is Skeptical Of S&P 500 Recovery To Early 2022 High
U.S. stocks faced another setback on Wednesday due to uncertainty surrounding interest rates and inflation. 
Via Benzinga
Topics Stocks
Exposures US Equities
Abbott Laboratories's Earnings Outlook
Via Benzinga
A Look Into Abbott Laboratories Inc's Price Over Earnings
Via Benzinga
Abbott Laboratories Unusual Options Activity For October 12
Via Benzinga
Earnings Scheduled For October 18, 2023
Companies Reporting Before The Bell • Procter & Gamble (NYSE:PG) is expected to report quarterly earnings at $1.71 per share on revenue of $21.67 billion. 
Via Benzinga
Amid Israel-Palestine And Ukraine Gas, Gold Up Big, Cathie Wood's ARKK Down Almost 4% - ETF Winners And Losers: Medium-Cap Returns
Via Benzinga
Topics ETFs
3 Reasons to Buy Abbott Laboratories Stock
Don't just focus on the recent past. 
Via The Motley Fool
Looking Into Abbott Laboratories's Recent Short Interest
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $2,900 Today
Via Benzinga
Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, But Middle East Worries Dominate
(Monday market open) Last week gave us a taste of earnings. The meal starts tomorrow and picks up steam as banks, airlines, and health care companies report. 
Via Benzinga
Tesla, Netflix Grab Earnings Spotlight This Week As Analysts Divided On Q3 Reporting Season: What's On Investors' Radar?
While analysts look forward to the unfolding reporting season with guarded optimism, they are skeptical regarding forward guidance. 
Via Benzinga
Abbott Laboratories Unusual Options Activity
Via Benzinga
Looking At Abbott Laboratories's Recent Unusual Options Activity
Via Benzinga
3 Dividend Growth Stocks You Can Buy and Hold Forever
Investors can sit back and let the dividends flow in with these great stocks. 
Via The Motley Fool
Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets
Higher-than-expected inflation data this week caught markets off guard, and the Israel-Hamas conflict is sending the markets running to safer assets. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Over Delivering: Big Banks Beat Expectations After Tough Quarter, But Market Eyes Middle East Warily
(Friday market open) Big bank earnings this morning threatened to take a back seat as geopolitical worries helped spark a rally in crude oil and sent more investors fleeing toward the perceived safety... 
Via Benzinga
Exposures Fossil Fuels
As Isreal-Palestine Conflict Escalates, Gold Ticks Up - ETF Winners And Losers: Medium-Cap Returns
Via Benzinga
Topics ETFs
Why Medtronic And Abbott Stocks Are Sinking
Medtronic plc. (NYSE: MDT) and Abbott Laboratories (NYSE: ABT) shares are trading lower on Wednesday after the U.S. 
Via Benzinga
Abbott Laboratories Explores Consumer Wearables Market As COVID Testing Sales Dwindle: CEO
Abbott Laboratories (NYSE: ABT) CEO Robert Ford, while speaking at the HLTH conference in Las Vegas, outlined the company's strategic move into the consumer wearables market.  
Via Benzinga
Exposures COVID-19
Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair. 
Via Benzinga
3 Dividend Kings Every Investor Should Own to Survive a Market Crash
Dividend stocks that raise their payout beat all other kinds of stocks, making Dividend Kings the best stocks to buy in a downturn. 
Via InvestorPlace
2 Magnificent Dividend Stocks to Buy Hand Over Fist in October
These two healthcare stocks are reliable passive income vehicles. 
Via The Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
These companies are helping change medicine; they could make boatloads of money along the way. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Abbott Laboratories And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Innovator U.S. 
Via Benzinga
Want $500 in Passive Income? Invest $3,500 Into These 3 Dividend Stocks and Wait 4 Years
A basket of passive income opportunities in oil and gas, renewable energy, and healthcare. 
Via The Motley Fool
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle
Abbott and Dexcom stocks have tumbled as GLP-1 drugs have gripped the nation. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.